Parkinsonism Hyperpyrexia Syndrome (Q99242): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
A síndrome de parkinsonismo-hiperpirexia é uma complicação rara porém potencialmente fatal observada em pacientes com doença de Parkinson, mais comumente subsequente a uma redução ou interrupção abrupta de medicamentos antiparkinsonianos. Clinicamente se assemelha à síndrome neuroléptica maligna com: rigidez, pirexia, rebaixamento do nível de consciência, instabilidade autonômica e elevação da creatina quinase sérica.
description / endescription / en
 
The parkinsonism-hyperpyrexia syndrome (PHS) is a rare but potentially fatal complication seen in Parkinson's disease patients, most commonly following abrupt reduction or cessation of antiparkinson medications. Clinically it resembles neuroleptic malignant syndrome with: rigidity, pyrexia, reduced consciousness level, autonomic instability, and serum creatine kinase elevation.

Revision as of 15:54, 16 August 2026

The parkinsonism-hyperpyrexia syndrome (PHS) is a rare but potentially fatal complication seen in Parkinson's disease patients, most commonly following abrupt reduction or cessation of antiparkinson medications. Clinically it resembles neuroleptic malignant syndrome with: rigidity, pyrexia, reduced consciousness level, autonomic instability, and serum creatine kinase elevation.
Language Label Description Also known as
default for all languages
ID_211461908
    English
    Parkinsonism Hyperpyrexia Syndrome
    The parkinsonism-hyperpyrexia syndrome (PHS) is a rare but potentially fatal complication seen in Parkinson's disease patients, most commonly following abrupt reduction or cessation of antiparkinson medications. Clinically it resembles neuroleptic malignant syndrome with: rigidity, pyrexia, reduced consciousness level, autonomic instability, and serum creatine kinase elevation.

      Statements